MedTech Resources

Free tool

FDA Breakthrough Devices

FDA's Breakthrough Devices Program speeds review of devices that may treat or diagnose life-threatening or irreversibly debilitating conditions better than existing options. FDA only names designated devices once they are authorized; designations still in review stay confidential. Designated devices can also qualify for Medicare's TCET coverage pathway and, in some cases, a New Technology Add-on Payment.

Last checked: Nov 19, 2026FDA Breakthrough Devices Program list last updated: June 30, 2026 (fetched 2026-11-11)

Authorized Breakthrough devices

206

Through June 30, 2026

Via De Novo

51

25% of authorizations

Via 510(k)

92

45% of authorizations

Via PMA

63

31% of authorizations

Authorizations by year

Select a year to filter the list.

Top specialties

From each device's FDA review panel, where the device is in our catalog.

  • Cardiology46
  • Laboratory Medicine & Pathology42
  • Orthopedic Surgery32
  • Neurology & Neurosurgery29
  • General & Plastic Surgery12
  • Radiology & Imaging12
  • GI, Urology & Nephrology11
  • Physical Medicine & Rehabilitation6
  • Ophthalmology4
  • Anesthesiology & Respiratory4

206 devices

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.